The For The Media website offers news releases for upcoming studies from The JAMA Network journals, PDFs of embargoed studies, and the weekly JAMA Report video.
LEARN MORE: About The JAMA Network Journals | For the Media FAQs

New from the JAMA Report

use this as template for single videos
Read the Video Script
Print

M-R-I TARGETED BIOPSY BETTER FOR DETECTING HIGH-RISK PROSTATE CANCER

INTRO: Prostate cancer is usually diagnosed with a standard biopsy, which randomly samples the entire prostate with the help of ultrasound. A newer, more targeted approach uses magnetic resonance imaging or M-R-I technology to help identify prostate cancer. A new study examined whether this new approach, using M-R-I, was better at detecting prostate cancer, especially higher risk tumors. Catherine Dolf has more in this week’s JAMA Report.

AUDIO

NATSO/FULL Runs:04

“We’ve met many patients like you who’s tumors are hidden.”

VIDEO

B-ROLL

Doctor talking to Ronald and showing him images of the prostate

AUDIO

VO

RONALD BRISCOE IS TALKING WITH DOCTORS ABOUT HIS PROSTATE CANCER.

AUDIO

SOT/FULL Super@:08 Ronald Briscoe – Prostate Cancer Survivor Runs:04

“My older brother, my father had it, and also my baby brother has it.”

VIDEO

B-ROLL

Doctors pointing to computer screen, cu of prostate

AUDIO

VO

DOCTORS FOUND HIS HIGH-RISK PROSTATE CANCER BY USING M-R-I GUIDED TECHNOLOGY.

AUDIO

NATSO/FULL Runs:04
“…MRI can tell us where tumors are hiding in the prostate, that’s not normally sampled.”

VIDEO

B-ROLL

Slide showing needles in prostate

AUDIO

VO

THIS APPROACH IS DIFFERENT FROM A STANDARD PROSTATE BIOPSY THAT USES ULTRASOUND.

AUDIO

SOT/FULL Super@:25 Peter A. Pinto, M.D., – National Cancer Institute, National Institutes of Health Runs:09
“Ultrasound insures that the needles hit the prostate but we don’t use the ultrasound to direct the needles into where the tumor may be present.”

AUDIO

SOT/FULL Super@:35 M. Minhaj Siddiqui, M.D., – National Cancer Institute, National Institutes of Health Runs:05

“We randomly try to get all the prostate sampled in hopes of catching the cancer.”

VIDEO

B-ROLL

Cu of Dr. Pinto, pan to Dr. Siddiqui dissolve to three doctors looking at the computer screen

AUDIO

VO

DOCTORS PETER PINTO AND MINHAJ (Min-ahj) SIDDIQUI (Sih-dee-Key) FROM THE NATIONAL CANCER INSTITUTE, NATIONAL INSTITUTES OF HEALTH ALONG WITH THEIR CO-AUTHORS LOOKED AT MORE THAN A THOUSAND MEN WITH ELEVATED P-S-A LEVELS. THESE MEN UNDERWENT BOTH AN M-R-I GUIDED TARGETED BIOPSY AND ALSO THE TRADITIONAL STANDARD BIOPSY USING ULTRASOUND ALONE. THE RESULTS OF BOTH BIOPSIES WERE THEN COMPARED.

AUDIO

SOT/FULL Super@1:02 Peter A. Pinto, M.D., – National Cancer Institute, National Institutes of Health Runs:13
The targeted MR guided biopsy had a 30 percent increase in detection of high-risk prostate cancer as compared to the traditional biopsies performed today.
(Video covering 1st part of bite: slide of MRI biopsy)

GXF FULL

JAMA COVER

AUDIO

VO

THE STUDY APPEARS IN JAMA, JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

AUDIO

SOT/FULL Super@1:14 Peter A. Pinto, M.D., – National Cancer Institute, National Institutes of Health Runs:12
Peter A. Pinto, M.D., – National Cancer Institute, National Institutes of Health
“Low risk cancers that are felt to be over diagnosed and over treated were actually detected 17 percent less in a targeted biopsy.”

VIDEO

Doctors walking down hallway

AUDIO

VO

WHILE THE RESULTS OF THIS STUDY ARE PRELIMINARY, ADDITIONAL RESEARCH IS STILL NEEDED TO UNDERSTAND HOW THIS NEW TECHNOLOGY MIGHT BE USED IN THE FUTURE.

AUDIO

SOT/FULL Super@1:34 M. Minhaj Siddiqui, M.D., – National Cancer Institute, National Institutes of Health Runs:18
“The benefit of doing that is that we maximize our ability to detect the high risk cancers that matter and also potentially avoid the harm of detecting cancer which is clinically insignificant and unlikely to cause problems for the patient.”

(Video covering middle of bite: Dr. Siddiqui pointing to computer)

AUDIO

SOT/FULL Super@1:51 Ronald Briscoe – Prostate Cancer Survivor Runs:04
“If you catch it early and get it done, taken care of, you get to live a longer life.”

VIDEO

B-ROLL

Ronald shaking hands with Dr. Pinto

AUDIO

VO

CATHERINE DOLF, THE JAMA REPORT.

TAG:BOTH THE TARGETED AND STANDARD PROSTATE BIOPSY CAN BE DONE IN THE OUT PATIENT SETTING.

INTRO: Prostate cancer is usually diagnosed with a standard biopsy, which randomly samples the entire prostate with the help of ultrasound. A newer, more targeted approach uses magnetic resonance imaging or M-R-I technology to help identify prostate cancer. A new study examined whether this new approach, using M-R-I, was better at detecting prostate cancer, especially higher risk tumors. Catherine Dolf has more in this week’s JAMA Report.

AUDIO

NATSO/FULL Runs:04

“We’ve met many patients like you who’s tumors are hidden.”

VIDEO

B-ROLL

Doctor talking to Ronald and showing him images of the prostate

AUDIO

VO

RONALD BRISCOE IS TALKING WITH DOCTORS ABOUT HIS PROSTATE CANCER.

AUDIO

SOT/FULL Super@:08 Ronald Briscoe – Prostate Cancer Survivor Runs:04

“My older brother, my father had it, and also my baby brother has it.”

VIDEO

B-ROLL

Doctors pointing to computer screen, cu of prostate

AUDIO

VO

DOCTORS FOUND HIS HIGH-RISK PROSTATE CANCER BY USING M-R-I GUIDED TECHNOLOGY.

AUDIO

NATSO/FULL Runs:04
“…MRI can tell us where tumors are hiding in the prostate, that’s not normally sampled.”

VIDEO

B-ROLL

Slide showing needles in prostate

AUDIO

VO

THIS APPROACH IS DIFFERENT FROM A STANDARD PROSTATE BIOPSY THAT USES ULTRASOUND.

AUDIO

SOT/FULL Super@:25 Peter A. Pinto, M.D., – National Cancer Institute, National Institutes of Health Runs:09
“Ultrasound insures that the needles hit the prostate but we don’t use the ultrasound to direct the needles into where the tumor may be present.”

AUDIO

SOT/FULL Super@:35 M. Minhaj Siddiqui, M.D., – National Cancer Institute, National Institutes of Health Runs:05

“We randomly try to get all the prostate sampled in hopes of catching the cancer.”

VIDEO

B-ROLL

Cu of Dr. Pinto, pan to Dr. Siddiqui dissolve to three doctors looking at the computer screen

AUDIO

VO

DOCTORS PETER PINTO AND MINHAJ (Min-ahj) SIDDIQUI (Sih-dee-Key) FROM THE NATIONAL CANCER INSTITUTE, NATIONAL INSTITUTES OF HEALTH ALONG WITH THEIR CO-AUTHORS LOOKED AT MORE THAN A THOUSAND MEN WITH ELEVATED P-S-A LEVELS. THESE MEN UNDERWENT BOTH AN M-R-I GUIDED TARGETED BIOPSY AND ALSO THE TRADITIONAL STANDARD BIOPSY USING ULTRASOUND ALONE. THE RESULTS OF BOTH BIOPSIES WERE THEN COMPARED.

AUDIO

SOT/FULL Super@1:02 Peter A. Pinto, M.D., – National Cancer Institute, National Institutes of Health Runs:13
The targeted MR guided biopsy had a 30 percent increase in detection of high-risk prostate cancer as compared to the traditional biopsies performed today.
(Video covering 1st part of bite: slide of MRI biopsy)

GXF FULL

JAMA COVER

AUDIO

VO

THE STUDY APPEARS IN JAMA, JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

AUDIO

SOT/FULL Super@1:14 Peter A. Pinto, M.D., – National Cancer Institute, National Institutes of Health Runs:12
Peter A. Pinto, M.D., – National Cancer Institute, National Institutes of Health
“Low risk cancers that are felt to be over diagnosed and over treated were actually detected 17 percent less in a targeted biopsy.”

VIDEO

Doctors walking down hallway

AUDIO

VO

WHILE THE RESULTS OF THIS STUDY ARE PRELIMINARY, ADDITIONAL RESEARCH IS STILL NEEDED TO UNDERSTAND HOW THIS NEW TECHNOLOGY MIGHT BE USED IN THE FUTURE.

AUDIO

SOT/FULL Super@1:34 M. Minhaj Siddiqui, M.D., – National Cancer Institute, National Institutes of Health Runs:18
“The benefit of doing that is that we maximize our ability to detect the high risk cancers that matter and also potentially avoid the harm of detecting cancer which is clinically insignificant and unlikely to cause problems for the patient.”

(Video covering middle of bite: Dr. Siddiqui pointing to computer)

AUDIO

SOT/FULL Super@1:51 Ronald Briscoe – Prostate Cancer Survivor Runs:04
“If you catch it early and get it done, taken care of, you get to live a longer life.”

VIDEO

B-ROLL

Ronald shaking hands with Dr. Pinto

AUDIO

VO

CATHERINE DOLF, THE JAMA REPORT.

TAG:BOTH THE TARGETED AND STANDARD PROSTATE BIOPSY CAN BE DONE IN THE OUT PATIENT SETTING.

Recent News Releases

News releases are made freely available to the general public. View all Past Releases >

JAMA

Releases For January 27, 2015

JAMA Internal Medicine

Releases For January 26, 2015